Talis Biomedical Corp
NASDAQ:TLIS 12:31:11 AM EDT
| Market Cap (Intraday) | 285.46M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.87 |
| 50-Day MA | $8.61 |
| 200-Day MA | $7.32 |
Talis Biomedical Corp Stock, NASDAQ:TLIS
1375 West Fulton Market, Suite 700, Chicago, Illinois 60607
United States of America
Phone: +1.650.433.3000
Number of Employees: 99
Description
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.